Peoples Financial Services Corp. Bristol Myers Squibb CO Transaction History

Peoples Financial Services Corp.

$214 Million
Q4 2024

A detailed history of Peoples Financial Services Corp. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Peoples Financial Services Corp. holds 20,226 shares of BMY stock, worth $1.21 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

20,226

Previous 20,481 1.25%

Holding current value

$1.21 Million

Previous $1.06 Million 7.93%

% of portfolio

0.53%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$51.92 - $59.94 $13,239 - $15,284	-255 Reduced 1.25%	20,226 $1.14 Million
Q3 2024 Oct 16, 2024	SELL	$39.66 - $51.75 $71,467 - $93,253	-1,802 Reduced 8.09%	20,481 $1.06 Million
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $13,322 - $17,539	-331 Reduced 1.46%	22,283 $925,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $393,963 - $446,678	-8,211 Reduced 26.64%	22,614 $1.23 Million
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $82,319 - $98,229	-1,698 Reduced 5.22%	30,825 $1.58 Million
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $15,630 - $17,477	-270 Reduced 0.82%	32,523 $1.89 Million
Q2 2023 Jul 11, 2023	SELL	$63.71 - $70.74 $75,177 - $83,473	-1,180 Reduced 3.47%	32,793 $2.1 Million
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $84,568 - $95,920	-1,287 Reduced 3.65%	33,973 $2.35 Million
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $98,953 - $117,175	-1,445 Reduced 3.94%	35,260 $0
Q3 2022 Oct 07, 2022	SELL	$0.13 - $76.84 $24 - $14,753	-192 Reduced 0.52%	36,705 $2.61 Million
Q2 2022 Jul 07, 2022	SELL	$72.62 - $79.98 $19,026 - $20,954	-262 Reduced 0.71%	36,897 $2.84 Million
Q1 2022 Apr 15, 2022	SELL	$61.48 - $73.72 $135,256 - $162,184	-2,200 Reduced 5.59%	37,159 $2.71 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $202,185 - $235,700	-3,770 Reduced 8.74%	39,359 $2.45 Million
Q3 2021 Oct 15, 2021	SELL	$59.17 - $69.31 $47,572 - $55,725	-804 Reduced 1.83%	43,129 $2.55 Million
Q2 2021 Jul 14, 2021	SELL	$61.91 - $67.42 $60,362 - $65,734	-975 Reduced 2.17%	43,933 $2.94 Million
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $42,131 - $47,385	-710 Reduced 1.56%	44,908 $2.84 Million
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $12,991 - $14,721	-225 Reduced 0.49%	45,618 $2.83 Million
Q3 2020 Oct 07, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.22%	45,843 $2.76 Million
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $2,466 - $2,884	45 Added 0.1%	45,943 $2.7 Million
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $15,822 - $22,993	-341 Reduced 0.74%	45,898 $2.56 Million
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $27,262 - $35,561	-554 Reduced 1.18%	46,239 $2.97 Million
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $28,869 - $34,229	675 Added 1.46%	46,793 $2.37 Million
Q2 2019 Jul 11, 2019	BUY	$44.62 - $49.34 $58,006 - $64,142	1,300 Added 2.9%	46,118 $2.09 Million
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $47,376 - $56,490	1,050 Added 2.4%	44,818 $2.14 Million
Q4 2018 Jan 14, 2019	SELL	$48.76 - $63.23 $52,417 - $67,972	-1,075 Reduced 2.4%	43,768 $2.27 Million
Q3 2018 Oct 12, 2018	BUY	$55.19 - $62.25 $280,089 - $315,918	5,075 Added 12.76%	44,843 $2.78 Million
Q2 2018 Jul 10, 2018	BUY	$50.53 - $62.98 $303,180 - $377,880	6,000 Added 17.77%	39,768 $2.2 Million
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $140,812 - $162,103	-2,350 Reduced 6.51%	33,768 $2.14 Million
Q4 2017 Jan 17, 2018	SELL	$59.94 - $65.35 $11,988 - $13,069	-200 Reduced 0.55%	36,118 $2.21 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $2.01 Million - $2.31 Million	36,318	36,318 $2.32 Million

Others Institutions Holding BMY

# of Institutions

2,760

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Financial Services Corp., based on Form 13F filings with the SEC.

News

Stay updated on Peoples Financial Services Corp. with notifications on news.

Account

Peoples Financial Services Corp. Bristol Myers Squibb CO Transaction History